首页> Addiction> The effectiveness, safety and cost‐effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non‐inferiority trial

The effectiveness, safety and cost‐effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non‐inferiority trial

导出原文传递

翻译打印收藏纠错

第一作者： Thomas Dennis

作者： Thomas Dennis ^[1] ; Farrell Michael ^[2] ; McRobbie Hayden ^[3] ; Tutka Piotr ^[4] ; Petrie Dennis ^[5] ; West Robert ^[6] ; Siahpush Mohammad ^[7] ; Gartner Coral ^[8] ; Walker Natalie ^[9] ; Mendelsohn Colin P. ^[10] ; Hall Wayne ^[11] ; Paul Christine ; Zwar Nicholas ; Ferguson Stuart G. ; Boland Veronica C. ; Richmond Robyn ; Doran Christopher M. ; Shakeshaft Anthony ; Mattick Richard P. ; Courtney Ryan J.

作者单位： School of MedicineUniversity of TasmaniaHobart,Australia ^[1] National Drug and Alcohol Research Centre (NDARC)University of New South Wales (UNSW)Sydney ^[2] School of Medicine and Public Health, Faculty of Health and MedicineUniversity of ^[3] Department of Behavioural Science and HealthUniversity College LondonLondon,UK ^[4] School of Public Health and Community MedicineUniversity of New South WalesSydney,Australia ^[5] College of Public HealthUniversity of Nebraska Medical CenterOmaha,United States ^[6] Centre for Indigenous Health Equity ResearchCentral Queensland UniversityBrisbane,Australia ^[7] Centre for Health Economics, Monash Business SchoolMonash UniversityMelbourne,Australia ^[8] National Institute for Health Innovation, School of Population HealthUniversity of AucklandAuckland ^[9] Faculty of Health and Behavioural Sciences, Centre for Youth Substance Abuse ResearchThe University ^[10] Faculty of Medicine, School of Public HealthThe University of QueenslandBrisbane,Australia ^[11]

关键词 Cost‐effectiveness cytisine randomized controlled trial smoking cessation tobacco varenicline

发布时间 2019-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交